Novartis AG
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
Last updated:
Abstract:
The present invention relates to monoclonal antibodies and antigen-binding fragments thereof that bind to human .beta.-klotho, and pharmaceutical compositions and methods of treatment comprising the same.
Status:
Application
Type:
Utility
Filling date:
1 Dec 2021
Issue date:
26 May 2022